Please login to the form below

Not currently logged in
Email:
Password:

Celgene poaches Sanofi Pasteur’s medical director

Adrian Kilcoyne announced as David Gillen’s replacement

Dr Adrian Kilcoyne has left his role as UK medical director at Sanofi Pasteur to join Celgene in the same role.

Taking on his new position this week, Dr Kilcoyne replaces Dr David Gillen who is promoted to head of global drug safety and risk management at Celgene.

He had been UK medical director at Sanofi's vaccines business Sanofi Pasteur since 2011, having joined the company from Roche where he was also medical director.

Other former roles include medical director at Baxter Healthcare and senior clinical research physician at Lilly.

This position at Lilly – which he took on in 2006 – was the first step in Dr Kilcoyne's pharma career and followed several years in primary and secondary care, as well as a spell as a specialist registrar in public health medicines at the Oxford Deanery.

Celgene's general manager for the UK Sam Pearce said: “He brings with him a wealth of experience that will prove a significant addition to the team, enabling us to continue to build on the already great work we are doing."

12th November 2013

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
certain health

Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...